{"id":"https://openalex.org/W2014109882","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.pl02.004","title":"The Novel BACE Inhibitor MK-8931 Dramatically Lowers CSF A Peptides in Healthy Subjects: Results from a Rising Single Dose Study (PL02.004)","display_name":"The Novel BACE Inhibitor MK-8931 Dramatically Lowers CSF A Peptides in Healthy Subjects: Results from a Rising Single Dose Study (PL02.004)","publication_year":2012,"publication_date":"2012-04-22","ids":{"openalex":"https://openalex.org/W2014109882","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.pl02.004","mag":"2014109882"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.78.1_meetingabstracts.pl02.004","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.pl02.004","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.pl02.004","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M. Forman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Forman","raw_affiliation_strings":["Merck Whitehouse Station NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Whitehouse Station NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Tseng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Tseng","raw_affiliation_strings":["Merck Whitehouse Station NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Whitehouse Station NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087420561","display_name":"John S. Palcza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Palcza","raw_affiliation_strings":["Merck Whitehouse Station NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Whitehouse Station NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064348006","display_name":"Jos Leempoels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163344","display_name":"SGS (Belgium)","ror":"https://ror.org/05ep1jp78","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210163344"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J. Leempoels","raw_affiliation_strings":["SGS Life Science Services Antwerpen  Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SGS Life Science Services Antwerpen  Belgium","institution_ids":["https://openalex.org/I4210163344"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022587039","display_name":"Steven Ramael","orcid":"https://orcid.org/0000-0002-5920-7191","observed_orcids":["https://orcid.org/0000-0002-5920-7191"]},"institutions":[{"id":"https://openalex.org/I4210163344","display_name":"SGS (Belgium)","ror":"https://ror.org/05ep1jp78","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210163344"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"S. Ramael","raw_affiliation_strings":["SGS Life Science Services   Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SGS Life Science Services   Belgium","institution_ids":["https://openalex.org/I4210163344"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004765077","display_name":"Gopal Krishna","orcid":"https://orcid.org/0000-0002-3163-3009","observed_orcids":["https://orcid.org/0000-0002-3163-3009"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Krishna","raw_affiliation_strings":["Merck Whitehouse Station NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Whitehouse Station NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101681989","display_name":"Lei Ma","orcid":"https://orcid.org/0000-0001-7502-446X","observed_orcids":["https://orcid.org/0000-0001-7502-446X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Ma","raw_affiliation_strings":["Merck Whitehouse Station NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Whitehouse Station NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111938300","display_name":"John A. Wagner","orcid":"https://orcid.org/0000-0002-0636-5006","observed_orcids":["https://orcid.org/0000-0002-0636-5006","https://orcid.org/0000-0003-0038-8511"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Wagner","raw_affiliation_strings":["Merck Whitehouse Station NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Whitehouse Station NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041539369","display_name":"Matthew D. Troyer","orcid":"https://orcid.org/0000-0002-0821-7509","observed_orcids":["https://orcid.org/0000-0002-0821-7509"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Troyer","raw_affiliation_strings":["Merck Whitehouse Station NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Whitehouse Station NJ","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"Meeting Abstracts 1","first_page":"PL02.004","last_page":"PL02.004"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bace-inhibitors","display_name":"BACE inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.7149999737739563},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.8370000123977661},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.7919999957084656},{"id":"https://openalex.org/keywords/amyloid-hypothesis","display_name":"amyloid hypothesis","score":0.9079999923706055},{"id":"https://openalex.org/keywords/amyloid-beta-40","display_name":"A\u03b240","score":0.7870000004768372},{"id":"https://openalex.org/keywords/amyloid-beta-1-42","display_name":"amyloid-beta 42","score":0.9860000014305115},{"id":"https://openalex.org/keywords/sappbeta","display_name":"sAPP\u03b2","score":0.7799999713897705},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9010000228881836},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9879999756813049},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7990000247955322},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6050000190734863},{"id":"https://openalex.org/keywords/csf-plasma-ratio","display_name":"CSF/plasma ratio","score":0.7649999856948853},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.4860000014305115},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48390182852745056},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4756336212158203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3870842456817627}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.78.1_meetingabstracts.pl02.004","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.pl02.004","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.pl02.004","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064541354","https://openalex.org/W2167272696","https://openalex.org/W2112329611","https://openalex.org/W2123191001","https://openalex.org/W1976106516","https://openalex.org/W2116774394","https://openalex.org/W2532837493","https://openalex.org/W2010046611","https://openalex.org/W1999657725","https://openalex.org/W2060598171"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"characterize":[2],"the":[3,9,26,43,49,52,94,105,209,240,296],"safety/tolerability,":[4],"pharmacokinetics":[5,97],"and":[6,96,116,153,167,172,180,207,231,257,263,279],"pharmacodynamics":[7],"of":[8,23,28,34,51,59,73,98,107,130,245,272,299],"novel":[10,53],"BACE":[11,32,54],"inhibitor":[12,55],"MK-8931":[13,56,74,108,131,158,226,273,289],"in":[14,25,62,75,88,119,146,165,170,178,187,197,228,234,284,331,425,430,462,470],"humans.":[15,63],"Background":[17],"Compelling":[18],"evidence":[19],"implicates":[20],"abnormal":[21],"accumulation":[22],"A\u03b2":[24,35,61,286],"pathogenesis":[27],"Alzheimer9s":[29],"disease":[30],"(AD).":[31],"inhibition":[33],"production":[36],"is":[37],"a":[38,175,202,229,281,291],"promising":[39],"approach":[40],"to":[41,92,100,134,144,222,275,294,368,374],"test":[42,295],"amyloid":[44,297],"hypothesis.":[45],"Here":[46],"we":[47],"report":[48],"effects":[50,106],"on":[57,112],"reduction":[58,233,283],"CSF":[60,113,171,181,193,217,242,261,285],"Design/Methods:":[65],"Two-part,":[66],"randomized,":[67],"double-blind,":[68],"placebo-controlled":[69],"single":[70],"rising-dose":[71],"study":[72,155],"healthy":[76],"adults,":[77],"18-45":[78],"years.":[79],"In":[80],"Part-1,":[81],"2":[82],"cohorts":[83,122],"(n=8/cohort,":[84,123],"6-active,":[85,124],"2-placebo)":[86],"participated":[87],"an":[89,322,349,362,390,403,416,437,453,477],"alternating-panel":[90],"design":[91],"evaluate":[93],"safety/tolerability":[95],"2.5":[99,133],"550-mg":[101,135,276],"MK-8931.":[102],"Part-2":[103],"assessed":[104],"(20-,":[109],"100-,":[110],"550-mg)":[111],"A\u03b240,":[114],"A\u03b242":[115,262],"sAPP\u03b2":[117,264],"concentrations":[118,159,194,219],"3":[120],"sequential":[121],"2-placebo).":[125],"Results:":[127],"Single":[128,270],"doses":[129,271],"from":[132],"were":[136,141,149,160,277],"well-tolerated;":[137],"adverse":[138],"events":[139],"(AE)":[140],"generally":[142],"mild":[143],"moderate":[145],"intensity.":[147],"There":[148],"no":[150,154],"serious":[151],"AEs":[152],"discontinuations.":[156],"Maximum":[157],"achieved":[161],"at":[162],"1-4.5":[163],"hr":[164,169,238],"plasma":[166,179,188,206],"4-6":[168],"there":[173],"was":[174,189,212,434,474],"dose-related":[176],"increase":[177],"exposure.":[182],"The":[183],"terminal":[184],"phase":[185],"half-life":[186],"16.5-23.5":[190],"hr.":[191],"Mean":[192],"post-peak":[195],"declined":[196],"parallel":[198],"with":[199,316,344,359,384,400,413,447],"plasma,":[200],"indicating":[201],"dynamic":[203],"equilibrium":[204],"between":[205],"CSF;":[208],"CSF:plasma":[210],"ratio":[211],"0.11.":[213],"Following":[214],"placebo":[215],"administration,":[216],"A\u03b240":[218,243],"increased":[220],"relative":[221],"baseline.":[223],"By":[224],"contrast,":[225],"resulted":[227],"dose-dependent":[230],"sustained":[232],"A\u03b240.":[235],"At":[236],"36":[237],"postdose,":[239],"mean":[241],"percent":[244],"baseline":[246],"(90%":[247],"confidence":[248],"interval)":[249],"was:":[250],"20-mg=79%":[251],"(71,":[252],"87%),":[253],"100-mg=25%":[254],"(17,":[255],"33%)":[256],"550-mg=8%":[258],"(0,":[259],"17%).":[260],"demonstrated":[265,280],"similar":[266],"reductions.":[267],"Conclusions:":[269],"up":[274],"well-tolerated":[278],"profound":[282],"peptides.":[287],"Thus,":[288],"presents":[290],"unique":[292],"opportunity":[293],"hypothesis":[298],"AD":[300],"pathogenesis.":[301],"Supported":[303],"by:":[304],"Merck.":[305],"Disclosure:":[307],"Dr.":[308,324,336,351,364,370,376,392,405,418,432,439,455,472],"Forman":[309,325],"has":[310,338,353,366,372,378,394,407,441],"received":[311,339,354,379,395,408,442],"personal":[312,340,355,380,396,409,443],"compensation":[313,341,356,381,397,444],"for":[314,342,357,382,398,411,445],"activities":[315,343,358,383,399,412,446],"Merck":[317,332,345,360,385,401,414,448,463],"&":[318,333,346,386,449,464],"Co.,":[319,334,347,387,450,465],"Inc.":[320,335,388,451,466],"as":[321,348,361,389,402,415,436,452,476],"employee.":[323,350,363,391,404,417,454],"holds":[326,420,457],"stock":[327,329,421,423,458,460],"and/or":[328,422,459],"options":[330,424,461],"Tseng":[337],"Palcza":[352],"Leempoels":[365],"nothing":[367,373],"disclose.":[369,375],"Ramael":[371],"Krishna":[377],"Ma":[393],"Wagner":[406,419,433],"compenstion":[410],"Merck,":[426],"which":[427,431,467,471],"sponsored":[428,468],"research":[429,469],"involved":[435,475],"investigator.":[438,478],"Troyer":[440,456,473]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}